LAS VEGAS — Off-label use of GLP-1 drugs by people with type 1 diabetes (T1D) did not lead to diabetic ketoacidosis (DKA) or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist ...

The Dallas Cowboys are one of the most exciting teams to watch entering Round 1 of the 2026 NFL Draft in Pittsburgh on Thursday night, with two first-round picks and several directions the team could ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

The proposed order is being announced weeks after a judge dismissed a similar lawsuit from X. The proposed order is being announced weeks after a judge dismissed a similar lawsuit from X. is a senior ...

Employer cost coverage increases likelihood of GLP-1 use (65% overall), peaking in ages 35–44 (75%) and declining sharply among workers ≥65 (37%). Behavioral support programs shift willingness to self ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

Keywords 👉 Learn how to evaluate the integral of a function. The integral, also called antiderivative, of a function, is the reverse process of differentiation. Integral of a function can be ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

Four new tax deductions are available on federal returns for eligible taxpayers whether they itemize deductions, such as claiming mortgage interest, or claim the standard deduction. All four big tax ...

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. In early March the U.S. Food and Drug Administration sent a warning letter to Novo ...

Brianna "Chickenfry" LaPaglia is slamming the use of Ozempic for weight loss. The reality TV star and Barstool Sports personality, 26, got candid about the growing use of GLP-1 weight loss medications ...